April 16, 2021
Article
April 14, 2021
Video
An interventional cardiologist discusses the observed cases of cerebral venous thrombosis in women administered the Johnson & Johnson COVID-19 vaccine.
April 13, 2021
Carlos del Rio, MD, discusses the United States' pandemic situation in assessing the blood clot events observed in 6 Johnson & Johnson vaccine recipients.
Jason Gallagher, PharmD, adds context behind the FDA and CDC's decision to pause and review blood clotting events in 6 women given the company's COVID-19 vaccine.
The federal agencies will advise states withhold administration of the Johnson & Johnson one-shot product while investigating risk of a rare blood clot disorder.
Our editor-in-chief writes on the role caregivers play in informing the public on the perks of a more vaccinated population.
April 09, 2021
The newest research of rare adverse events among patients administered the vaccine highlights that venous or arterial thrombosis can develop in unexpected regions, including the brain or abdomen, 5-20 days after administration.
A new commentary from experts highlight the evolving understanding of antibody response in vaccinated transplant patients.
April 05, 2021
An expert stresses the need to consider individuals' worry over information—and even their history with systemic biases.
Vaccine access and new cases are both increasing. An expert discusses earning trust in at-risk communities.
